First-in-human Study of Orally Administered KT-579 in Healthy Adult Participants
Clinical trial NCT07412288 · RECRUITING
Trial details
- NCT number
- NCT07412288
- Sponsor
- Kymera Therapeutics, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-23
- Primary completion
- 2026-12-01
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.